-
公开(公告)号：US11918594B2
公开(公告)日：2024-03-05
申请号：US17956139
申请日：2022-09-29
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/675 , A61P25/18
CPC classification number: A61K31/675 , A61P25/18
Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.
-
公开(公告)号：US11858895B2
公开(公告)日：2024-01-02
申请号：US17946457
申请日：2022-09-16
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: C07D209/16
CPC classification number: C07D209/16
Abstract: Disclosed are novel aminated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The aminated psilocybin derivative compounds may be chemically synthesized.
-
公开(公告)号：US11752130B2
公开(公告)日：2023-09-12
申请号：US17951530
申请日：2022-09-23
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/404 , A61P25/18 , C07D209/32 , C07D209/16 , C07D209/30
CPC classification number: A61K31/404 , A61P25/18 , C07D209/16 , C07D209/30 , C07D209/32
Abstract: Disclosed are novel carboxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a carboxyl or Carboxylic acid derivative containing compound.
-
公开(公告)号：US20250100967A1
公开(公告)日：2025-03-27
申请号：US18971774
申请日：2024-12-06
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: C07D209/16
Abstract: Disclosed are novel hydroxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced synthetically or biosynthetically.
-
公开(公告)号：US12133856B2
公开(公告)日：2024-11-05
申请号：US18390228
申请日：2023-12-20
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/675 , A61P25/18
Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.
-
Patent Agency Ranking
公开(公告)号：US20240246924A1
公开(公告)日：2024-07-25
申请号：US18541304
申请日：2023-12-15
Applicant: Enveric Biosciences Canada Inc.
Inventor： Kaveh Matinkhoo , David James Press , Jessica Lee , Charlie Cai , Jillian M. Hagel , Peter J. Facchini
IPC: C07D317/60 , C07D317/58 , C07D317/64 , C07D405/06 , C07D413/06
CPC classification number: C07D317/60 , C07D317/58 , C07D317/64 , C07D405/06 , C07D413/06
Abstract: Disclosed are novel fused mescaline derivative compounds, notably substituted ethylamine fused heterocyclic mescaline derivatives, including substituted ethylamine fused dioxolane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.
-
公开(公告)号：US20240116866A1
公开(公告)日：2024-04-11
申请号：US18510936
申请日：2023-11-16
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: C07D209/16
CPC classification number: C07D209/16
Abstract: Disclosed are novel aminated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The aminated psilocybin derivative compounds may be chemically synthesized.
-
公开(公告)号：US20230398097A1
公开(公告)日：2023-12-14
申请号：US18227688
申请日：2023-07-28
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/404 , A61P25/18 , C07D209/32 , C07D209/16 , C07D209/30
CPC classification number: A61K31/404 , A61P25/18 , C07D209/32 , C07D209/16 , C07D209/30
Abstract: Disclosed are novel carboxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a carboxyl or Carboxylic acid derivative containing compound.
-
公开(公告)号：US20230357185A1
公开(公告)日：2023-11-09
申请号：US17886075
申请日：2022-08-11
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Ye Cai , Kaveh Matinkhoo , David James Press , Glynnis Elizabeth Jensen , Peter J. Facchini
IPC: C07D209/16 , C07D403/12 , C07D401/12 , C07D405/12
CPC classification number: C07D401/12 , C07D209/16 , C07D403/12 , C07D405/12
Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
-
公开(公告)号：US20230321040A1
公开(公告)日：2023-10-12
申请号：US18203823
申请日：2023-05-31
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Kaveh Matinkhoo , Peter J. Facchini
IPC: A61K31/4045 , C07D209/20 , A61P25/00
CPC classification number: A61K31/4045 , C07D209/16 , A61P25/00 , C07D209/20
Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
-
-
-
-
-
-
-
-
-
Search Results
46
records
(took 0.018 seconds)
